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Abstract. Porous nanosilica (PNS) as promising targeted drug nanocarriers has become a new 
area of interest in recent years due to their tunable pore sizes and large pore volumes, high 
chemical and thermal stability, and excellent biocompatibility. These unique structures of PNS 
facilitate effective protecting drugs from degradation and denaturation. However, it has certain 
limitations for being used in pharmaceutical such as a burst release of encapsulated drugs. In this 
study, the effects of grafting cyclodextrin (CD) as gatekeeper through the biodegradable 
disulfide bonds on doxorubicin (DOX) release was investigated. The morphology and pore 
channel structures of these modified PNS were assessed by transmission electron microscopy 
(TEM). Fourier transform infrared spectroscopy (FTIR) was utilized to evaluate the functional 
groups on PNS surface. In vitro tests were conducted for the drug loading and releasing 
efficiency. The results demonstrated that the prepared DOX@PNS-SS-A/CD was of spherical 
shape with an average diameter of 45 nm, drug loading efficiency of 60.52 ± 2.12 %, and 
sustained release. More importantly, MTT assay showed that PNS-SS-A/CD was biocompatible 
nanocarriers. In addition, the modified PNS incorporating DOX could significantly eliminate the 
toxicity of free DOX. As a result, the development of PNS-SS-A/CD may offer a promising 
candidate for loading and sustained release of DOX in cancer therapy.  
Keywords: drug delivery system, porous nanosilica, cyclodextrin, doxorubicin. 
Classification numbers: 2.2.4, 2.5.3, 2.7.1. 
1. INTRODUCTION 
During the last three decades, porous nanosilica (PNS) has emerged as a promising targeted 
drug nanocarrier due to the unique porous structure, chemical and thermal stabilities, 
biocompatibility, biodegradability, and surface functionality that ensures the controlled release 
of a variety of anticancer drugs [1 - 4]. The porous architecture of PNS allows loading a large 
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number of drugs inside the pores and protecting them from degradation as well as denaturation 
[5]. However, the encapsulated drug in bare PNS could not overcome the burst release 
phenomenon that is one major drawback needed to be surpassed by other techniques [6, 7]. 
Thus, many different methods functionalizing the PNS surface have been developed. 
Nevertheless, several studies demonstrated that such conditions can control and delay the rate of 
drug release. 
 
Figure 1. Schematic illustration showing the formation and redox-sensitive intracellular delivery of             
DOX-loaded PNS-SS-A/CD nanoparticles. 
 
Stimuli-responsive PNS has been developed to induce the controlled drug release triggered 
by temperature, light, pH, redox potential, magnetic, electric and mechanical stimuli, as well as 
enzyme and chemical reactions [8, 9]. Among different types of stimuli-responsive PNSs, redox 
stimulus is competitive PNS for loading drugs in the pores because it takes advantage of 
intracellular conditions, namely the presence of glutathione (GSH) in tumor cells that is 
approximately three times higher than that in normal cells. Moreover, GSH in tumor cell leads to 
cleave redox‐groups and trigger the delivery of therapeutic agents [10]. Therefore, stimuli-
responsive PNSs which have disulfide bonds (S–S) as redox-sensitive groups and disulfide-
linked cyclodextrin (CD) as gatekeepers could be easily cleaved in the presence of GSH which 
makes it an attracting redox-responsive system to release drugs at the targeted tumor sites [11 - 
13]. The structure of PNS delivery systems, in particular, was modified to be capable of 
encapsulating a variety of therapeutic agents at exceptionally high loadings [14]. For instance, 
Abdous et al. reported the redox-responsive drug delivery system using β-Cyclodextrin to block 
the pore entrances of PNS through a biodegradable disulfide bond to achieve controlled release 
of curcumin (CUR) [15]. The results showed that the maximum loading efficiency was 88.55% 
at 43 h of loading time and 1.22 % of the weight ratio. The maximum CUR release was obtained 
at 5.16 of pH and 107 h of release time. This novel [β-CD@PEGylated KIT-6] nanoparticles 
exhibited stimuli-responsive drug release property and can be further used as a promising 
candidate for cancer treatment [15].  
Herein, we report on the redox-controlled release of Doxorubicin (DOX) entrapped in the 
pore of PNS that is blocked by the surface-grafted redox-responsive SS-A/CD. The mechanism 
of this system is schematically described in Figure 1. The modified PNS was characterized using 
 
 
Dai Hai Nguyen, Thai Thanh Hoang Thi  
 
 
452 
different techniques such as Fourier transform infrared (FTIR) and transmission electron 
microscope (TEM). The drug releasing behavior of the prepared DOX@PNS-SS-A/CD was also 
determined using dithiothretol (DTT) which was used to reduce –SS- in PNS-SS-A/CD. 
Additionally, MTT assay was performed to determine whether the PNS-SS-A/CD may reduce 
the toxicity to HeLa cells of DOX. The aim of this study is to create an efficiency redox-
sensitive PNS for controlled drug delivery. 
2. MATERIALS AND METHODS 
2.1. Materials 
Ethanol absolute (EtOH, 46.07 g/mol), toluene was purchased from Scharlab, Spain. 
Tetraethyl orthosilicate 98 % (TEOS, 208.33 g/mol), N,N-dimethyl formamide (DMF, 73.09 
g/mol), dithiothreitol (DTT, 154.25 g/mol), ethylenediamine (EDA, 60.10 g/mol), 1-ethyl-3-3 
dimethylaminopropyl carbodimide (EDC, 191.70 g/mol), amantadine hydrochloride (A, 187.71 
g/mol), and doxorubicin (DOX, 579.98 g/mol) were obtained from Sigma-Aldrich, USA. N-
cetyl-nnn-trimethylammonium bromide (CTAB, 364.45 g/mol), acetone nitrile (ACN, 41.05 
g/mol) were purchased from Merck, Germany. β-cyclodextrin (β-CD, 1134.99 g/mol) was 
purchased from TCI, Japan. 3,3'-dithiodipropionic acid (DTDP) 99 % (210.26 g/mol) and (3-
aminopropyl)triethoxysilane (APS) 99 % (221.37 g/mol) were purchased from Acros Organics, 
Belgium. All chemicals were of ACS reagent grade and used without further purification. 
2.2. Synthesis of PNS-SS-A and PNS-SS-A/CD 
Based on the literature with minor modification, the overall PNS-SS-A synthesis can be 
described in four steps [2]. First, PNS was synthesized by the sol-gel process including TEOS as 
alkoxide precursors, CTAB as surfactant, ethanol/water/ammonia solution (NH3) as a solvent. 
Deionized water (deH2O, 64 mL), ethanol (11.25 mL, 0.2 mol), CTAB (2.6 g, 7.1 mmol), and 
2.8 % NH3 solution (0.55 mL, 0.9 mmol) were mixed at 60 
o
C with a stir-bar for 30 min. TEOS 
(8 mL, 35.8 mmol) were added drop-wise to the surfactant solution within 5 min under stirring 
for 2 h, and then filtered. The filtrated solution was dialyzed using a dialysis membrane (MWCO 
6-8 kDa, Spectrum Laboratories, Inc., USA) against deH2O for 4 days at room temperature. The 
deH2O was changed 5-6 times per day. The dialyzed mixture was then lyophilized to obtain 
PNS. Secondly, the amine functionalized PNS (PNS-NH2) were prepared by the interaction 
between APS (1 mL, 5.7 mmol) and PNS (1 g) in toluene (30 mL). The reaction was performed 
at room temperature under stirring and nitrogen conditions for 24 h. The suspension was 
dialyzed using a dialysis membrane (MWCO 6-8 kDa) for 4 days against 2 M of acetic 
acid:ethanol (1:1 v/v, 250 mL). Acetic acid:ethanol solution was changed 5-6 times per day, and 
then the tube containing PNS was immersed into deH2O to remove acetic acid/EtOH for 1 day. 
The deH2O was changed 5-6 times a day and the resulting solution was lyophilized to generate 
PNS-NH2 as white powder. Thirdly, the conjugation of the disulfide bond onto PNS-NH2 was 
carried out by the reaction between PNS-NH2 and DTDP to form PNS-SS-COOH. In brief, the 
obtained PNS-NH2 (1 g) and EDC (0.14 mL, 0.77 mmol) were dissolved in deH2O (20 mL) 
under stirring for 10 min. Then, DTDP (0.16 g, 0.77 mmol) in DMF (20 mL) were added into 
the mixture and the reaction was maintained for 24 h. After that, the sample was purified by a 
dialysis membrane (MWCO 6-8 kDa) against deH2O at room temperature for 4 days. This 
purified solution was lyophilized to obtain PNS-SS-COOH. Finally, the adamantane conjugated 
PNS-SS-COOH (named as PNS-SS-A) was synthesized. The reaction including PNS-SS-COOH 
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(1 g), a solution (0.77 mmol) and EDC (0.64 mmol) was stirred at room temperature for 24 h. 
After completing reaction, the mixture was filtered and then dialyzed for 4 days. The deH2O was 
changed 5-6 times per day. The mixture after dialysis was lyophilized to obtain PNS-SS-A.  
To prepare PNS-SS-A/CD, 200 mg of PNS-SS-A was immersed in 40 ml of deionized 
water and then mixed with 44 mg of β-CD. The sample was dialyzed in a cellulose tube (MW 
12000-14000 Da) for 4 days with the water changing of 4 times/day. The lyophilization was 
done to obtain PNS-SS-A. 
2.3. Characterization 
Morphology and size of the resulting PNS were observed with a TEM (JEM-1400, JEOL, 
Tokyo, Japan). The accelerating voltage was operated at 200 kV. The copper formvar/carbon 
grids were utilized. The samples were dispended and sonicated in ethanol. Dropping the samples 
on the grids, they were dried for 24 hours before measuring. 
FTIR spectra were performed (Nicolet 5700, Thermo Electron Corporation, MA, USA) in 
the transmittance mode at the wavenumber range of 4000 - 500 cm
−1
 to evaluate the functional 
groups on silica surface. The PNS, PNS-SS-A and PNS-SS-A/CD were mixed in potassium 
bromide salt, then pressed into the thin pellet which would be scanned by FTIR 
spectrophotometer. 
The samples were outgassed at 150 °C for 3 h, then nitrogen adsorption-desorption 
isotherms were determined by NOVA 1000e system (Quantachrome Instruments, USA). 
X-ray diffraction measurements (Rigaku DMAX 2200PC, Rigaku Americas Co., USA) 
were performed to identify the phase of materials. The diffractometer was equipped with Cu/Kα 
radiation (λ = 0.15405 nm), the scanning rate was 4°/min. 
2.4. Drug loading 
The model drug DOX was used in drug loading and drug releasing study. Typically, 100 
mg PNS-SS-A were immersed in 20 ml of DOX solution in deionized water (0.2 mg/ml). After 
stirring for 24 hours under dark conditions, the DOX loaded nanoparticles were dialyzed in 5 
hours to remove excessive DOX. The β-CD (22 mg) was used to seal the loading nanoparticles 
[16]. The product was obtained as DOX@PNS-SS-A/CD. Similarly, the unmodified PNS 
loading DOX (DOX@PNS) was prepared for control group. The particles were used for 
subsequent tests of DOX release. DOX loaded inside the nanoparticles was determined by UV 
absorption at 541 nm. The obtained particles were freeze-dried prepared for controlled release 
experiments. These experiments were repeated 3 times and the results were a mean of time 
determination.  
2.5. Drug released behavior 
The drug released study was performed by the introduction of reducing agent DTT. The 
DTT triggered release of DOX from two different DOX@PNS-SS-A/CD samples were obtained 
by dialysis method with cellulose dialysis membrane (MW = 12000-14000 Da). The released 
buffer to stimulate body fluid environment contained PBS buffer (pH 7.4, 0.01 M) and DTT (5 
mM) as external stimulus to breakdown disulfide linkage. The DOX release profile was 
calculated by measuring the absorbance of the released DOX solution at wavelength 541 nm 
using UV-Vis spectroscopy. 
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2.6. Cell study 
To evaluate the effect of DOX loaded PNS-SS-A/CD on killing cancerous cells in the 
comparison with CD, PNS-SS-A/CD and free DOX, HeLa cell lines were used. HeLa cells were 
cultured on 96-well plates for 1 days with 1.5 × 10
4
 cells/well. Then they were washed with 
DPBS for three times. The cell media (DMEM mixing with 10 % of FBS and 1 % of PS) were 
mixed with CD, PNS-SS-A/CD (100 μg/mL), free DOX, and DOX loaded PNS-SS-A/CD (eq. 
DOX concentration of 5 μg/mL) to add respectively into each HeLa cell well. Each sample was 
repeated three times. All cells were kept for 72 hours in an incubator at 37 
o
C, relative humidity 
of 98 % and CO2 of 5 %. After each 24-hour contacting those materials, the cells were 
characterized of the viability using resazurin test method. To measure the viability, the media 
was removed and added 10 μL of resazurin solution (0.2 mg/mL). The well-plates were kept to 
be reacted for 4 hours. Then 100 μL of cell media of each well was moved into 96-well plate to 
read with microplate reader at excitation/emission of 560/590 nm. 
3. RESULTS AND DISCUSSION 
3.1. Characteristics 
The morphology and pore channel structures of prepared particles were analyzed with 
TEM. The white products highly and stably suspended in solution with centrosymmetric radial 
mesopores. The bare PNS and modified PNS (PNS-SS-A/CD) were in the diameter range of 40-
50 nm (Figure 2a, b). The size and shape of PNS and modified PNS were comparable, so the 
nanoparticles could keep their morphology after the functionalization. This synthesized PNS 
diameter was almost similar with mesoporous nanosilica of Menard et al. [17] However, the 
PNS-SS-A/CD diameter was significantly smaller than other modified PNS. For example, the 
poly(acrylic acid) functionalized mesoporous silica nanoparticles were 180 nm [18], the 
aminopropyl modified nanoporous silica nanoparticles designed by Wang et al. were 100 - 130 
nm [19]. Al-Nadaf et al. utilized polyethylene glycol or polypropylene glycol to wrap 
mesoporous silica nanoparticles and obtained the modified MSNs of 357 or 580 nm [20]. It 
could be reasoned that the polymers with long chains enlarged the MSN size, while our study 
utilized the small molecules not causing any change much in nanoparticle dimension. However, 
the mesopore arrays couldn’t be clearly observed in aqueous solution, because of the polymer 
envelope (Figure 2b).  
a) b)
 
Figure 2. TEM images of prepared PNS (a) and PNS-SS-A/CD (b). 
The surface modification of PNS was determined by FTIR. In Figure 3, three FTIR spectra 
showed the peak of 1092 cm
-1
 was assigned to asymmetric stretching of Si-O-Si bond in the 
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silica nanoparticles [21]. After grafting amantadine on the nanoparticle surface to form PNS-SS-
A, a new peak appeared at 1530 cm
-1
 attributed to the primary amine groups (Figure 3b). In 
addition, the peaks of 2930 and 2860 cm
-1
 assigned to C-H stretching vibration were also 
observed in PNS-SS-A spectra. The broad peak from 1100 to 1300 cm
-1
 overlapped the signals 
for the A units on the nanoparticle surface [22]. These FTIR results indicated that the 
amantadine was conjugated successfully onto MSN surface. In the Figure 3c, a peak at ∼1643 
cm
-1
 corresponding to the H-O-H bending of β-CD structure [23] that implied the β-CD-capped 
PNS-SS-A. 
 
Figure 3. FTIR spectra of PNS (a), PNS-SS-A (b), PNS-SS-A/CD (c). 
To determine the crystalline species of mesoporous silica structures, XRD was carried out. 
Figure 4 showed the measured XRD pattern of PNS and PNS-SS-A/CD. In two XRD spectra of 
bare PNS (Figure 4a) and modified PNS-SS-A/CD (Figure 4b), the broad band of 24 degree was 
observed that was assigned as the characteristic diffraction peak due to (100), (110) and (200) 
planes of amorphous silica nanosphere [24]. However, the diffraction intensity of PNS-SS-A/CD 
seemed smaller than that of bare PNS. This could be ascribed to the presence of organic moiety 
amount in PNS-SS-A/CD. Altogether, the modification of cyclodextrin and amantadine on PNS 
surface did not change the amorphous phase of PNS. 
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Figure 4. XRD patterns of PNS (a) and PNS-SS-A/CD (b). 
To characterize the porous materials, N2 adsorption-desorption method is considered as a 
well-established technique. Figure 5 showed the nitrogen adsorption–desorption isotherm of 
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PNS-SS-A/CD nanoparticles. Following the IUPAC classification, this isotherm was belonging 
to the IV(a) type associated with adsorption in mesoporous materials containing 2-50 nm of pore 
width. The lower relative pressures (P/Po, Po was saturation pressure of adsorption) were applied 
to the smaller volume, vice versa, the higher P/Po was used for the larger volume. At 417.56 
cm
3
/g of PNS-SS-A/CD, the pressure was plateau, the pore volume of PNS-SS-A/CD was 
determined. As our previous study, the pore volume of bare PNS was reported as 710.40 cm
3
/g . 
So the functionalization of PNS using adamantine and -CD caused the reduction on the pore 
volume of silica nanoparticles. Moreover, the hysteresis loop at P/Po range of 0.38 - 0.98 was 
appeared in this isotherm. This feature was associated with the metastability of the mesoporous 
adsorption. Taken together, the porous structure of silica nanoparticles were retained well after 
modifying with adamantine and -CD. 
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Figure 5. Nitrogen adsorption–desorption isotherm of PNS-SS-A/CD. 
 
3.2. Drug loading 
To demonstrate the drug carrier ability of PNS and modified-PNS, DOX was encapsulated 
inside these systems and their loading efficiency was tested. The loading efficiencies of DOX in 
PNS and CD modified-PNS were 19.59 ± 2.14 % and 60.52 ± 2.12 %, respectively. The major 
obstacle of unmodified surface silica nanoparticles was the low loading efficiency, drug 
molecules would start leaking out of the particles intermediately when they were introduced in 
water so PNS exhibited a little bit lower DOX loading capacity than modified-PNS. The 
gatekeeper system and CD end-capped illustrated the efficiency in increasing drug loading level. 
Also the loading efficiency of PNS-SS-A/CD (60.52 %) was comparable to other similar studies. 
Guo et al. formed the -CD-poly(N-isopropylacrylamide)@mesoporous silica-ferrocene with 
doxorubicin loading efficiency of 66.68 - 71.04 % [25]. In addition, Gupta et al. reported the 
hyaluronic acid-capped mesoporous titania nanoparticles with doxorubicin loading capacity of 
18.3 % [26]. Xin et al. reported the amino modified multimodal nanoporous silica nanoparticles 
with loading capacity of 34.52 % [19]. Despite of various drug loading efficiency/capacity, each 
system achieved its own outstanding properties and showed excellent effect on killing cancerous 
cells. 
3.3. Evaluation of drug release behavior  
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 The released amount of DOX was calculated based on the measurement of DOX 
calculated from the standard curve. As seen in Figure 6 (black column), the rapid release of 
DOX in DOX@PNS system was observed because the matrix-entrapped drug would start 
leaking out the biodegradable carrier right after the system was introduced in aqueous solution. 
However, the DOX@PNS system could slow down the DOX release compared to free DOX due 
to the hindrance space. The DOX@PNS-SS-A/CD showed the lowest amount of released DOX 
due to the highest hindrance caused by both porous silica and the capping CD. In case of using 
the media containing DTT, the release profile in two different media could exhibit the significant 
change only for DOX@PNS-SS-A/CD system. In fact, as showed in Figure 6 (white column), 
the released DOX amount in DTT media was two-fold higher than that in PBS for DOX@PNS-
SS-A/CD, while there was no change observed for free DOX and DOX@PNS-SS-A. This 
phenomenon indicated the important role of CD capped outside the porous nanosilica particles. 
The capping CD was not only to limit the DOX release in normal condition but also to enhance 
the DOX release rate in the DTT solution as reducing agents. These results implied that 
DOX@PNS-SS-A/CD could limit the free DOX leak out in the normal tissues, but induce the 
burst release in cancerous organs due to high level of glutathione being a reducing agent. Thus, 
the DOX@PNS-SS-A/CD being glutathione-sensitive system was successfully designed to 
cause burst release in cancer cells to increase the killing effect, while less leakage was occurred 
in the normal cell conditions. Looking at another strategies, sulfonate-functionalized 
doxorubicin-loaded mesoporous silica nanoparticles exploited the presence of serum to enhance 
the drug loading and to accelerate their release ability, almost 50 % of doxorubicin were released 
after 6 hours [27]. Gupta et al. exploited hyaluronic acid as targeting agent of CD44 on cancer 
cell to fabricate the doxorubicin release system, they also achieved over 60 % doxorubicin going 
out after 24 hours [26]. Although each strategy obtained the various release profile, all showed 
the good effect on killing cancer cells. 
 
Figure 6. Percentage of release of DOX, DOX@PNS-SS-A and DOX@PNS-SS-A/CD in pH 7.4 PBS 
with (white column) and without DTT (5 mM, black column) at 24 h. 
3.4. In vitro cytotoxicity 
The in vitro cytotoxicity effect of the -CD, PNS-SS-A/CD, DOX@PNS-SS-A/CD, and 
free DOX against Hela cells was determined. Figure 7 described the Hela cell viability when 
they were incubated with four aforementioned samples. In -CD and PNS-SS-A/CD media, 
Hela cells were grown up normally, 100 % viability compared to fresh media is an acceptable 
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value for non-cytotoxicity. This data confirmed that these materials did not cause any effect on 
Hela cells. In case of DOX@PNS-SS-A/CD test, Hela cell viability was significantly decreased 
to 70 % after 24-hour incubation, and continuously down to 55 % and 20 % after 48 and 72 
hour. Taken together, the killing effect was caused by released DOX. In addition, the decreased 
viability of Hela cells contacting DOX@PNS-SS-A/CD was comparable to that of free DOX 
that implied the DOX@PNS-SS-A/CD system did not compromise the efficiency of free DOX 
in killing cancerous cells. These results confirmed the promising application of PNS-SS-A/CD 
with controlled drug delivery and highly killing effect being comparable to free drug. 
 
Figure 7. Viability of Hela cells incubated with CD, PNS-SS-A/CD (100 μg/mL), free DOX, and DOX 
loaded PNS-SS-A/CD (eq. DOX concentration of 5 μg/mL) for 24, 48 and 72 h, respectively. The cells 
were exposed to the samples for the indicated times. The data represent the mean values ± the standard 
deviation (SD) (n = 4). 
4. CONCLUSIONS 
The -CD functionalized porous nanosilica through disulfide linkages has been 
successfully prepared. The introduction of disulfide in drug delivery system was to offer the 
redox-responsive mechanism, the capping -CD was utilized with a function of gatekeeper. In 
cancerous cells, the disulfide linkage can be effectively cleaved by antioxidant agents, resulting 
in the detachment of -CD to open the door of porous nanosilica particles for the burst release of 
drug. Specifically, the size of DOX@PNS-SS-A/CD was less than 100 nm that is suitable for 
penetrating inside the cells. The loading efficiency was highly 60.52 ± 2.12 %. The release rate 
of DOX@PNS-SS-A/CD was controlled and induced by a reducing agent. Therefore, the 
DOX@PNS-SS-A/CD exhibited its ability as a promising candidate for drug delivery system 
with stimuli response. 
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